Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
DoorDash Invests in Also as Part of $200 Million Funding Round
The investment is part of a partnership between Also...
Reid Wiseman, Christina Koch, Victor Glover and Jeremy Hansen
In just two days, four astronauts could launch toward...
Tijeras rezoning, Clovis suspects, Rain chances, Bosque restoration, Elephant escape
Tuesday's Top Stories Tuesday's Five Facts Controversial plan...